The estimated Net Worth of Robert Bowen is at least $30.9 Million dollars as of 15 May 2015. Robert Bowen owns over 6,222 units of Abiomed stock worth over $29,058,490 and over the last 16 years Robert sold ABMD stock worth over $1,868,943.
Robert has made over 17 trades of the Abiomed stock since 2011, according to the Form 4 filled with the SEC. Most recently Robert sold 6,222 units of ABMD stock worth $421,354 on 15 May 2015.
The largest trade Robert's ever made was exercising 40,786 units of Abiomed stock on 15 July 2013 worth over $239,006. On average, Robert trades about 5,641 units every 50 days since 2008. As of 15 May 2015 Robert still owns at least 76,265 units of Abiomed stock.
You can see the complete history of Robert Bowen stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is C/O ABIOMED, INC, 22 CHERRY HILL DR, DANVERS, MA, 01923.
Over the last 21 years, insiders at Abiomed have traded over $148,507,587 worth of Abiomed stock and bought 232,354 units worth $4,276,073 . The most active insiders traders include Michael R Minogue, Eric A Md Rose, and David M Weber. On average, Abiomed executives and independent directors trade stock every 16 days with the average trade being worth of $5,341,900. The most recent stock trade was executed by Martin P Sutter on 17 February 2022, trading 4,000 units of ABMD stock currently worth $1,258,840.
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Abiomed executives and other stock owners filed with the SEC include: